Can antidepressants make you more anxious at first?

It’s day three. The new bottle is beside your coffee, and you’re checking your pulse with the concentration of someone defusing a tiny bomb. You started medication because anxiety was already too loud. Now you’re sleeping lightly, your stomach feels jumpy, and every sensation seems to be asking, “Is this normal?”

The honest answer is that some people do feel more anxious, restless, irritable, or activated soon after starting an antidepressant. Many don’t. When it happens, it can be brief and manageable, or it can be intense enough that the prescriber needs to change the plan. The useful move isn’t to grit your teeth or panic-scroll a list of every side effect ever reported. It’s to notice the pattern and communicate it clearly.

Early activation is real, but it isn’t one tidy syndrome

Clinicians sometimes use terms such as activation or jitteriness/anxiety syndrome for a cluster that can include nervousness, agitation, irritability, insomnia, shakiness, or a keyed-up feeling after an antidepressant is started. The research is messier than the label sounds. A systematic review found that studies defined and measured the problem inconsistently, so estimates of how often it occurs varied widely.

That uncertainty matters. It means nobody can look at the name of a medication and predict exactly how your first week will feel. It also means every uncomfortable sensation shouldn’t automatically be blamed on the prescription. Anxiety itself fluctuates. Sleep loss, caffeine, alcohol, cannabis, decongestants, stimulants, thyroid problems, and the understandable vigilance that comes with starting something new can all join the scene.

NICE guidance still advises clinicians to tell people that agitation, anxiety, and suicidal thinking can increase during the initial stage of antidepressant treatment. That isn’t a reason to avoid treatment. It’s a reason to have a monitoring plan instead of sending you home with a bottle and a cheerful little shrug.

Feeling different quickly doesn’t tell you whether treatment will work

Side effects can appear before the hoped-for benefit is clear. That timing can feel deeply unfair. You’ve done the brave, practical thing, and your reward seems to be worse sleep plus an internal motor you didn’t order.

Early anxiety doesn’t prove the medication is wrong for you, and it doesn’t prove it will eventually work. The evidence hasn’t established activation as a reliable forecast of response. Your prescriber has to weigh what changed, how severe it is, how long it has lasted, which medicine and dose are involved, and what risks would come with waiting, adjusting, or switching.

I’ll often ask for a before-and-after description rather than the word “anxious.” Are you worrying more, physically unable to sit still, waking every hour, snapping at people, having panic attacks, or feeling unusually driven and impulsive? Those experiences can point to different problems. Precision gives the appointment somewhere useful to go.

Restlessness deserves more attention than a generic “bad day”

One important distinction is between ordinary nervous energy and severe inner restlessness, sometimes called akathisia. Akathisia can feel like you have to pace, rock, shift, or keep moving because staying still is unbearable. It can be intensely distressing. If that’s happening, contact the prescriber promptly rather than waiting for the next routine visit.

Also report a striking change in sleep and energy, especially if you need far less sleep and still feel unusually energized, talkative, confident, impulsive, or sped up. Those changes can have several explanations, but they deserve timely assessment for a possible mood elevation or medication reaction. Your new online shopping empire at 2 a.m. isn’t automatically a personality breakthrough.

Seek urgent help for new thoughts of suicide, feeling unable to stay safe, severe agitation, frightening behavior changes, confusion with fever and marked tremor or muscle stiffness, or another rapidly worsening reaction. The FDA advises close monitoring for clinical worsening, suicidality, and unusual behavior changes when antidepressants are started or doses change, with particular attention to children, adolescents, and young adults.

Bring your prescriber a small log, not a courtroom case

You don’t need perfect data. For several days, note the medication time, the symptom, when it began, its intensity, sleep, caffeine or substance use, and what the symptom stopped you from doing. Add any missed doses or other medication changes. One line per day is enough.

Then send a concrete message: “Since starting on Monday, I’ve been waking four times a night and pacing for about an hour after each dose. This is new, and it’s getting harder to function. What should I do?” That is far more useful than “I feel weird,” though “I feel weird” is a perfectly respectable draft.

Don’t double, skip, stop, or change the dose without guidance unless emergency clinicians tell you otherwise. Stopping suddenly can create another set of symptoms, and the safest next step depends on the medication, dose, time taken, medical history, and reaction. A prescriber may recommend closer observation, a timing change, a slower approach, a different medication, or urgent evaluation. An article can’t choose among those for you.

A good start includes a way to reach someone

Before you leave a prescribing visit, you should know what common early effects might occur, which symptoms should trigger a message, whom to contact after hours, and when follow-up is planned. If you didn’t get that information, it’s reasonable to ask now. Medication treatment shouldn’t be a guessing contest with pharmacy lighting.

A brief baseline can help too. Before a change, write down your usual sleep, anxiety, energy, and ability to sit still. You won’t capture every variable, but you’ll have something sturdier than trying to reconstruct last Tuesday while worried.

Keep the log short enough that you’ll actually use it. Monitoring should help you recognize a change, not turn the day into continuous surveillance. If tracking itself is feeding panic, tell the prescriber that too.

Tell someone you trust that you’re starting or changing treatment if that feels safe. They don’t need to monitor your every facial expression. They can simply know what changes you and your prescriber want watched, especially if you’ve had suicidal thoughts, severe agitation, or mood elevation before.

If you’re having thoughts of suicide or you don’t feel able to stay safe, call or text 988 in the United States. If there’s immediate danger, severe confusion, a medical emergency, or you may act on those thoughts, call 911 or go to the nearest emergency department. You’re not overreacting by treating safety as the main event.

Sources: National Institute for Health and Care Excellence, Depression in adults: treatment and management (NG222, 2022, accessed August 2026); U.S. Food and Drug Administration, antidepressant Medication Guide and boxed-warning guidance (accessed August 2026); Sinclair and colleagues, jitteriness/anxiety syndrome systematic review, British Journal of Psychiatry (2009); Jakubovski and colleagues, SSRI and SNRI dose-response meta-analysis for anxiety disorders, Depression and Anxiety (2019).